Skip to main content
NEUROCRINE BIOSCIENCES INC logo

NEUROCRINE BIOSCIENCES INC — Investor Relations & Filings

Ticker · NBIX ISIN · US64125C1099 LEI · 549300FECER0XBN49756 US Manufacturing
Filings indexed 1,500 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country US United States of America
Listing US NBIX

About NEUROCRINE BIOSCIENCES INC

https://www.neurocrine.com/

Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company that discovers, develops, and commercializes treatments for neurological, neuroendocrine, and neuropsychiatric disorders. The company's portfolio includes FDA-approved therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, and classic congenital adrenal hyperplasia. With a focus on addressing unmet medical needs, Neurocrine Biosciences also maintains a robust clinical development pipeline to investigate potential new medicines for various diseases and conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-18 English
10-Q - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)
Interim / Quarterly Report
2026-05-05 English
8-K - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)
Regulatory Filings
2026-05-05 English
8-K - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)
Regulatory Filings
2026-04-06 English
3 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
Director's Dealing
2026-03-17 English
4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)
Director's Dealing
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.